Strota/ Newsroom/ 2026-07-20

TORNTPHARM (Torrent Pharmaceuticals Ltd.): Acquisition / M&A

Strota Newsroom · session of 2026-07-20 · 20 Jul 12:44 · TORNTPHARM stock page →

Torrent Pharmaceuticals Limited has informed the Exchange about General Updates - Allotment of 4,19,22,416 fully paid-up… Historically, acquisition / m&a events have moved TORNTPHARM-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Torrent Pharmaceuticals has completed the amalgamation of J. B. Chemicals & Pharmaceuticals with itself, according to an exchange filing dated 20 July. The company allotted 4,19,22,416 fully paid-up equity shares to eligible shareholders of J. B. Chemicals as of the record date of 17 July 2026. The stock closed at ₹4,956.9 on 20 July, up 4.07% from its previous close of ₹4,763, outperforming a 0.47% decline in the Nifty.

Events like this—acquisition or M&A announcements—have historically shown a 48.9% win rate across 141 comparable instances in Strota's database, with a net edge of 0.213 percentage points. This means slightly less than half of such events have produced positive returns in the relevant window, and the average outcome has been marginally positive relative to market movement.

The stock trades at a price-to-earnings ratio of 77.93 and price-to-book of 20.07, with a market capitalisation of ₹1,68,319 crore. It is 6.35% below its 52-week high of ₹5,085.8 and 41.07% above its 52-week low of ₹3,376.4. Relative volume stood at 1.7 times average, with the 14-day RSI at 53.0. The stock remains above both its 50-day and 200-day simple moving averages, though no golden cross is present.

The filing confirms the share allotment has been executed; it does not establish whether the integration will meet operational or financial targets, nor does it comment on whether the current valuation reflects those outcomes.

The catalyst

Torrent Pharmaceuticals Limited has informed the Exchange about General Updates - Allotment of 4,19,22,416 fully paid-up Equity shares of the Company to the eligible shareholders of J. B. Chemicals & Pharmaceuticals Limited as on the Record Date i.e. 17th July, 2026, in terms Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

TORNTPHARM right now

trading +4.07% on the day; P/E 77.93; RSI 53.0. Full TORNTPHARM analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.